Corvus Pharmaceuticals, Inc. Common Stock logo

Corvus Pharmaceuticals, Inc. Common Stock (CRVS) Technical Analysis

$12.21-0.81%

Market is closed - opens 7 PM, 19 May 2026

Insights

  • Corvus Pharmaceuticals Common Stock is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for Corvus Pharmaceuticals Common Stock stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, Corvus Pharmaceuticals Common Stock stock is in a downtrend↘️
  • Based on analysis of the Pivot Points, the current market trend for Corvus Pharmaceuticals Common Stock stock suggests that it is a good time to sell or bad time to initiate a fresh position

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
34.19
Neutral
Stochastic
2.68, 26.01
Neutral
Ultimate Oscillator
28.74
Buy
Stochastic Relative Strength Index
30.14, 57.0
Neutral
Moving Average Convergence Divergence
-0.34, -0.06
Neutral

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
15.09
Sell
20
15.51
Buy
50
15.16
Sell

Exponential Moving Average

Period (Days)

Value

Action

10
14.74
Sell
20
15.11
Sell
50
15.27
Buy

Volume Weighted Moving Average

Period (Days)

Value

Action

10
14.71
Sell
20
15.51
Sell
50
15.16
Sell

Double Exponential Moving Average

Period (Days)

Value

Action

10
14.1
Sell
20
14.75
Sell
50
15.58
Sell

Triple Exponential Moving Average

Period (Days)

Value

Action

10
13.59
Sell
20
14.45
Sell
50
14.74
Sell

Pivot

Pivot

Value

Resistance L3
17.89
Resistance L2
16.86
Resistance L1
15.26
Pivot Point
14.24
Support L1
12.63
Support L2
11.61
Support L3
10.0

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.